AzTrials
AzTrials

Recovery PeriodNCT07786480

Recovery Time After Excision vs Limberg Flap for Pilonidal Sinus

An observational study of Recovery Period, run by Sargodha Medical College at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

There is a difference mean recovery time in patients undergoing Limberg Flap operation versus simple excision of Pilonidal sinus. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Recovery Period
What is being tested?
Limberg flap operation and Simple excision
How many people
154 participants
Where
1 sitePakistan
Study dates
25 Feb 2025to 28 Dec 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: Patient admitted in Hospital

Who may be able to join

  • Paticnts of both gender
  • Age of 18-60 years
  • ASA physical status I and II
  • Diagnosed as having pilonidal sinus

Who cannot join

  • Patients with recurrent pilonidal sinus disease
  • Pegnant or lactating females
  • Patients with a psychiatric discase
  • ASA physical status ≥3

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Dr Faisal Masood teaching Hospital Sargodha

    Sargodha, Punjab Province, 40100

Other trials in Pakistan

About this study

Official title: Comparison of Recovery Time Period in Patients Undergoing Simple Excision vs Limberg Flap Operation of Pilonidal Sinus

There is a difference mean recovery time in patients undergoing Limberg Flap operation versus simple excision of Pilonidal sinus.

Conditions
Recovery Period
Being tested
Limberg flap operation, Simple excision

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Limberg flap operationProcedure or surgery

    Pilonidal surgery by excision and closure using the Limberg flap technique. The excision and flap site will be mapped The ratio of length to width will be 60%. This rhomboid shape incision will be made and continued to the post sacral fascia and the tissue will be excised. Then the fascio-cutaneous flap will be divided from the underlying gluteus muscle and rotated to the defect. The wound will be closed with 2-0 nylon string after hemo-vaccum drain placement. Routine dressing will be performed and removed the day after operation

  • Simple excisionProcedure or surgery

    Pionidal sinus surgery by excision with primary closure only. The excision site will be marked 1 cm away from the sinus. Then an elliptical incision will be made that extended to the post sacral fascia. The tissue will be resected, and proper hemostasis will be done using minimum electrocautery. Tnen the wound will be closed in layers and a vaccum drain (Redivac) will be placed in a subcutaneous plane. Patients will be followed for 4 weeks and recovery time will be noted as per operational definition

Study groups in NCT07786480
Study groupRoleWhat they receive
Closure ure using limberg flap techniqueNot described
Receives: Procedure: Limberg flap operation
Closure by simple excisionNot described
Receives: Procedure: Simple excision

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Recovery time

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2026
  2. Study start25 Feb 2025
  3. Primary completion23 Dec 2025
  4. Study completion28 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
154 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07786480
Sponsor's protocol ID
SMC-GS-2026-0011
Status last verified
Aug 2026
First submitted
22 Aug 2026
Last updated
26 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Recovery Period, run by Sargodha Medical College at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Recovery time (time frame: 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in